Invention Grant
![2-azaspiro[3.4]octane derivatives as M4 agonists](/docs/US/2023-01-10/US11548865B2/abs.jpg.600x600.jpg)
- Patent Title: 2-azaspiro[3.4]octane derivatives as M4 agonists
-
Application No.: US17065360Application Date: 2020-10-07
-
Publication No.: US11548865B2Publication Date: 2023-01-10
- Inventor: Amy Calhoun , Xin Chen , Kevin Matthew Gardinier , Edward Charles Hall , Keith Jendza , Nancy Labbe-Giguere , James Neef , Daniel Steven Palacios , Ming Qian , Michael David Shultz , Christopher G. Thomson , Kate Yaping Wang , Fan Yang
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: C07D401/04
- IPC: C07D401/04 ; A61K45/06
![2-azaspiro[3.4]octane derivatives as M4 agonists](/abs-image/US/2023/01/10/US11548865B2/abs.jpg.150x150.jpg)
Abstract:
Provided herein are compounds according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, and R7 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) as well as the use of such compounds as M4 receptor agonists.
Public/Granted literature
- US20210107889A1 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS Public/Granted day:2021-04-15
Information query
